Literature DB >> 24992689

Selective elimination of human pluripotent stem cells by a marine natural product derivative.

Ting-Fang Kuo1, Di Mao, Nao Hirata, Bilon Khambu, Yasuhisa Kimura, Eihachiro Kawase, Hiroki Shimogawa, Makoto Ojika, Norio Nakatsuji, Kazumitsu Ueda, Motonari Uesugi.   

Abstract

One of the current obstacles to stem cell therapy is the tumorigenic potential of residual undifferentiated stem cells. The present study reports rediscovery of a synthetic derivative of okadaic acid, a marine polyether toxin, as a reagent that selectively induces the death of human pluripotent stem cells. Cell-based screening of 333 cytotoxic compounds identified methyl 27-deoxy-27-oxookadaate (molecule 1) as a substrate of two ATP-binding cassette (ABC) transporters, ABCB1 (MDR1) and ABCG2 (BCRP), whose expression is repressed in human embryonic stem cells and induced pluripotent stem cells. The results demonstrate that selective elimination of human pluripotent stem cells can be achieved by designing cytotoxic small molecules with appropriate ABC-transporter selectivity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992689     DOI: 10.1021/ja501795c

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

Review 1.  Technical approaches to induce selective cell death of pluripotent stem cells.

Authors:  Ho-Chang Jeong; Seung-Ju Cho; Mi-Ok Lee; Hyuk-Jin Cha
Journal:  Cell Mol Life Sci       Date:  2017-02-28       Impact factor: 9.261

Review 2.  Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.

Authors:  Angelos Oikonomopoulos; Tomoya Kitani; Joseph C Wu
Journal:  Mol Ther       Date:  2018-03-06       Impact factor: 11.454

3.  Enzymatically Forming Intranuclear Peptide Assemblies for Selectively Killing Human Induced Pluripotent Stem Cells.

Authors:  Shuang Liu; Qiuxin Zhang; Adrianna N Shy; Meihui Yi; Hongjian He; Shijiang Lu; Bing Xu
Journal:  J Am Chem Soc       Date:  2021-09-16       Impact factor: 16.383

Review 4.  Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart.

Authors:  Shigeru Miyagawa; Satsuki Fukushima; Yukiko Imanishi; Takuji Kawamura; Noriko Mochizuki-Oda; Shigeo Masuda; Yoshiki Sawa
Journal:  Curr Gene Ther       Date:  2016       Impact factor: 4.391

5.  MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells.

Authors:  Callum J C Parr; Shota Katayama; Kenji Miki; Yi Kuang; Yoshinori Yoshida; Asuka Morizane; Jun Takahashi; Shinya Yamanaka; Hirohide Saito
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

Review 6.  Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes.

Authors:  Silvia Pellegrini; Valentina Zamarian; Valeria Sordi
Journal:  Transpl Int       Date:  2022-08-24       Impact factor: 3.842

7.  Kyoto probe-1 reveals phenotypic differences between mouse ES cells and iTS-P cells.

Authors:  Chika Miyagi-Shiohira; Issei Saitoh; Masami Watanabe; Hirofumi Noguchi
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.